Marrone Bio Innovations, Inc Closes $9.2 Million Public Offering Of Common Stock With Full Exercise Of Over-Allotment Option Post author:Sam Post published:April 30, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Reckitt CEO's $17B Predicament December 26, 2017 Real Estate Developers Eye Boston’s South End for Life Science Campus November 13, 2017 <b>Ramaswamy</b> Launches Another New Biotech to Work on Phase III-Ready Drug From Merck & Co. June 5, 2017
<b>Ramaswamy</b> Launches Another New Biotech to Work on Phase III-Ready Drug From Merck & Co. June 5, 2017